Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,995 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors.
Yamamoto T, Jingu K, Shirata Y, Koto M, Matsushita H, Sugawara T, Kubozono M, Umezawa R, Abe K, Kadoya N, Ishikawa Y, Kozumi M, Takahashi N, Takeda K, Takai Y. Yamamoto T, et al. Among authors: takahashi n. BMC Cancer. 2014 Jun 23;14:464. doi: 10.1186/1471-2407-14-464. BMC Cancer. 2014. PMID: 24957478 Free PMC article.
Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.
Yamamoto T, Kadoya N, Shirata Y, Koto M, Sato K, Matsushita H, Sugawara T, Umezawa R, Kubozono M, Ishikawa Y, Kozumi M, Takahashi N, Ito K, Katagiri Y, Takeda K, Jingu K. Yamamoto T, et al. Among authors: takahashi n. Radiat Oncol. 2015 Feb 7;10:35. doi: 10.1186/s13014-015-0343-6. Radiat Oncol. 2015. PMID: 25886315 Free PMC article.
[Radiotherapy for Thyroid Cancer].
Jingu K, Maruoka S, Umezawa R, Takahashi N. Jingu K, et al. Among authors: takahashi n. Gan To Kagaku Ryoho. 2015 Jun;42(6):666-9. Gan To Kagaku Ryoho. 2015. PMID: 26199238 Japanese.
Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocols.
Umezawa R, Jingu K, Matsushita H, Sugawara T, Kubozono M, Yamamoto T, Ishikawa Y, Kozumi M, Takahashi N, Katagiri Y, Kadoya N, Takeda K, Ariga H, Nemoto K, Yamada S. Umezawa R, et al. Among authors: takahashi n. BMC Cancer. 2015 Oct 27;15:813. doi: 10.1186/s12885-015-1836-2. BMC Cancer. 2015. PMID: 26506988 Free PMC article.
Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma.
Yamamoto T, Kadoya N, Takeda K, Matsushita H, Umezawa R, Sato K, Kubozono M, Ito K, Ishikawa Y, Kozumi M, Takahashi N, Katagiri Y, Onishi H, Jingu K. Yamamoto T, et al. Among authors: takahashi n. Radiat Oncol. 2016 May 26;11:72. doi: 10.1186/s13014-016-0651-5. Radiat Oncol. 2016. PMID: 27229710 Free PMC article.
Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study.
Takahashi N, Yamamoto T, Matsushita H, Sugawara T, Kubozono M, Umezawa R, Ishikawa Y, Kozumi M, Katagiri Y, Tasaka S, Takeda K, Takeda K, Dobashi S, Jingu K. Takahashi N, et al. J Radiat Res. 2016 Nov;57(6):655-661. doi: 10.1093/jrr/rrw048. Epub 2016 Jul 15. J Radiat Res. 2016. PMID: 27422935 Free PMC article.
Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma.
Takeda K, Matsushita H, Kubozono M, Tanabe T, Ishikawa Y, Yamamoto T, Kozumi M, Takahashi N, Katagiri Y, Tasaka S, Fukui K, Takeda K, Fujishima F, Ichinose M, Jingu K. Takeda K, et al. Among authors: takahashi n. Intern Med. 2016;55(22):3325-3330. doi: 10.2169/internalmedicine.55.6990. Epub 2016 Nov 15. Intern Med. 2016. PMID: 27853077 Free PMC article.
5,995 results